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We evaluated in a qualitative systematic review the ef-
fect of N-methyl-o-aspartate (NMDA) receptor antago-
nists on reducing postoperative pain and analgesic con-
sumption beyond the clinical duration of action of the
target drug (preventive analgesia). Randomized trials
examining the use of an NMDA antagonist in the peri-
operative period were sought by using a MEDLINE
(1966-2003) and EMBASE (1985-2003) search. Refer-
ence sections of relevant articles were reviewed, and
additional articles were obtained if theyevaluated post-
operative analgesia after the administration of NMDA
antagonists. The primary outcome was a reduction in
pain, analgesic consumptiory or both in a time period
beyond fi'n'e half-lives of the drug under examination.
Secondary outcomes included time to first analgesic re-
quest and adverse effects. Forty articles met the inclu-
sion criteria (24 ketamine, 12 dextromethorphan, and 4
magnesium). The evidence in favor of preventive anal-
gesia was strongest in the case of dexkomethorphan
and ketamine, with 67"/" and 58%, respectively, of stud-
ies demonstrating a reduction in pain" analgesic con-
sumptioq orbothbeyond the clinical duration of action
of the drug concerned. None of the four studies exam-
ining magnesium demonstrated preventive analgesia.
he N-methyl-n-aspartate (NMDA) receptor is an
excitatory amino acid receptor that has been im-
plicated in the modulation of prolonged pain
states in animal models (1). NMDA antagonists, such
as ketamine and dextromethorphan, have been shown
to be useful in the reduction of acute postoperative
pain, analgesic consumption, or both when they are
added to more conventional means of providing an-
algesia, such as opioids and nonsteroidal antiinflam-
matorlr drugs, in the perioperative period (1,2).
lntraoperative and postoperative noxious inputs
may cause central sensitization, but analgesic inter-
ventions given be{ore the noxious stimulus may atten-
uate or block sensitization and, hence, reduce acute
pain (3). The concept of preemptive analgesia was
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initially put forward by Crile (4) and then by Wall (3),
who suggested that the administration of opioids or
local anesthetics before surgery might reduce the
C-fiber-induced injury barrage associated with inci-
sion and, thereby, the intensity of postoperative pain.
This first definition of preemptive analgesia did not
include the imperative to compare a preoperative in-
tervention with a postoperative intervention. This re-
quirement, adopted shortly thereafter (5), imposed a
constraint that limited the demonstration of preemp-
tive analgesia to experimental designs with less poten-
tial for clinically significant effects. The evidence in
support of preemptive analgesia by this strictest of
definitions has been equivocal, and a recent systematic
review of the literature examining the role of preemp-
tive analgesia and the role of timing of analgesia dem-
onstrated no overall benefii of this concept (6).
F{owever, since the introduction of the term preemp-
tiae analgesia irito the pain and anesthesia literature,
the concept has evolved. The previously held belief
that it was the surgical incision that triggered central
sensitization has been expanded to include the sensi-
tizing effects of preoperative noxious inputs and pain,
as well as other noxious intraoperative and postoper-
ative stimuli. This would suggest that the previous
definition of preemptive analgesia is too restrictive (7),
because an analgesic intervention given after surglcal
incision (e.g., during or after surgery) may also reduce
central sensitization and thus decrease oostonerative
pain intensity. We can evaluate this possibility oily-by
adding a control group that does not receive the an-
algesic intervention, a group that receives the irrter-
vention before and after surgery, or both groups. Un-
fortunately, many negative studies examining for a
preemptive analgesic effect do not include appropri-
ate control groups and hence may be missing an im-
portant effect.
The term preaentiae analgesia (8) was infroduced to
emphasize the fact that central sensitization is induced
by noxious preoperative and postoperative inputs and
has been used to describe a reduction in postoperative
pain intensity, analgesic use, or both beyond the clin-
ical duration of action of the target preventive drug
(9,10). Thus, in the absence of a postincisional inter-
vention, the finding that pain or analgesic consump-
tion is reduced beyond the pharmacological duration
of action relative to an untreated or placebo control
condition is evidence of a preventive analgesic effect.
Thus, the aim of preventive analgesia is to reduce
central sensitization that arises from noxious inputs
across the entire perioperative period and not just
from those brought about by incision. The concept of
preventive analgesia, therefore, has greater clinical rel-
evance than does preemptive analgesia (8,10).
Although many drugs have demonstrated evidence
of preventive analgesic benefit (9), treatments that are
likely to prevent the development of central excitabil-
ity may have the greatest benefit. Because antagonists
at the NMDA receptor have potential for attenuating
central sensitization, we conducted a systematic re-
view of the literature to determine the extent to which
NMDA antagonists have yielded preventive analgesic
effects when given during the perioperative period.
Methods
We systematically conducted a search of the MEDLINE
and EMBASE databases ftom1966 to April2003 (MED-
LINE) and from 1985 to Apri12003 (EMBASE) by using
the following key words and limiting the search strategy
to English language reports in humans: "pre-emptive
analgesia" or "preemptive analgesia," "pre-operative,"
"preoperative," "post-operatTve," "postoperative," " pre-
incision " "preincision," " post-rtcision," "postincisi.ory"
and "timing." These key words were then cross-
referenced with the following: NMDA, ketamine,
memantine, amantadine, dextromethorphan, mag-
nesium, and methadone. Reference sections of rele-
vant articles were reviewed, and additional articles
were obtained if they evaluated postoperative anal-
gesia after the administration of NMDA antagonists.
Authors were not contacted for original data.
The criteria for assessing the quality of reports as
described by Jadad et al. (11) were used, and the
quality score was recorded. Studies without random-
ization and blinding were excluded. Therefore, the
minimum score of an included study was 2, and the
maximum score was 5. In addition to a randomized
protocol and double-blinded assessment of pain and
analgesic use, studies also had to include a report of
pain or hyperalgesia by using a reliable and valid
measure (e.g., r'isual analog scale, numeric rating
scale, verbal descriptor scale, quantitative sensqly
testing, or pressure algometry), a report of analgesic
consumption, and, for sfudies that assessed the effect
of timing according to the definition of preventive
analgesia, consumption of analgesics reported at a
point in time that exceeded the duration of action of
the iarget drug whose effect on postoperative pain
was being examined. For the purposes of this review,
a point in time equivalent to five half-lives of the drug
under examination was taken as exceeding the clinical
duration of action of the drug. This criterion, although
stringent, was chosen to ensure that observed effects
were not simply direct analgesic effects of residual
drug. The stated half-life of each drug was determined
and found to be 3 h for ketamine (12), 2-4 h for
dextromethorphan (1q,2A h for methadone (14), and
5 h for ionized magnesium (15). The final criterion was
the absence of methodological problems that render
results ambiguous and make interpretation difficult.
A preventive analgesic effect was confirmed if pain,
analgesic consumption, or bottr were significantly re-
duced (P < 0.05) five halflives beyond the adminis-
tration of the NMDA antagonist under examination or
Table 1. Excluded Studies by Criteria
Criteria not fulfilled
No.
Studies References
Inadequate blinding
No control group
Not randomized
No preventive analysis possible
beyond five half-lives
Inadequate pain measure
Case report
Not perioperative
Negative preemptive study with no
placebo control
Table 2. Study Quality Score by Drug and Positive or
Negative Outcome
6
11
9
53
9
z
4
z
16-21
2212
J.FII
42-94
95-103
104, 105
706-109
110, nl
Drug
Positive
studiesn
Negative P
studieso value
Ketamine
Dextromethorphan
Magnesium
3.s (2-s)
NA
4 ()4\
4.s (4-s)
4 (3-s)
0.7
0.8
NA
NA : not applicable
' Median (range).
if the first analgesic request occurred beyond five half-
lives of the drug concemed, and if it was significantly
lo4ger than that in the control group (P < 0.05). Pos-
itive preemptive analgesic studies in which pain, an-
algesic consumption, or both were reduced in a pre-
ircisional group in relation to a postincisional group
and placebo control were also included. However,
negative preemptive studies that did not include a
placebo control group were excluded, because it could
not be determined whether a preventive analgesic
effect had occurred (both preincisional and postinci-
sional groups may have received analgesic benefit,
and these groups could not be contrasted with a pla-
cebo control group).
Differences in study quality (11) were analyzed with
the Mann-Whitney U-test by using SPSS for Windows
Version 9.0 (SPSS Inc., Chicago, IL). P ( 0.05 r,t'as
considered significant.
Results
The MEDLINE and EMBASE searches identified 136
articles that examined the use of an NMDA antagonist
for perioperative pain management. Forty studies ful-
filled the inclusion criteria outlined previously.
Ninety-six studies were excluded. The most frequent
reason for exclusion (n :53 studies) was the failure to
design the study to test for a preventive analgesic
effect (i.e., absence of pain and/or analgesic data be-
yond five half-lives of the d*g). Two studies were
excluded because they were negative preemptirre
studies with no placebo control group. Two were case
reports, 4 did not examine a surgical population, and
35 were excluded because of methodological flaws.
Table 1, [16-20,2I-25,26-36,37*50,51-61,62-75,7 6 -
86,87-100,\01-111lllists the studies that were ex-
cluded from the review and shows which of the in-
clusion criteria were not met.
Of the included studies, 24 examined the use of
ketamine (772-135), 12 examined dextromethorphan
(136-147), and 4 examined magnesium (148-151). A
total of 2034 patients were studied, and the number of
patients in the studies ranged from a minimum of 18
in a study using a crossover design (133) to a maxi-
mum of 121 patients in the largest randomized con-
trolled trial (112). Study quality across the positive and
negative studies for each drug is presented in Table 2.
There were no significant differences in study quality
between studies that found positive or negative out-
comes for each drug.
Quantitative analysis of the degree of analgesic ben-
efit was not performed because of the variability of
consistency of reporting of numerical pain and anal-
gesic consumption data. Thirty-six (90%) of 40 studies
presented data in tables together with significance
levels (P values) or in other formats that allowed for
assessment of the degree of benefit but did not allow
for quantitative analysis. Instead, data have been pre-
sented in table format for each drug, as performed for
othef recent qualitative systematic reviews (152).
Twenty-four studies examined ketamine (Table 3),
arrd-14 (58'/o) demonstrated a positive preemptive or
preventive analgesic effect. Three studies used a pre-
emptive design (7\3,175,134), and 21 studies used a
preventive design. Of the 10 negative studies, 6 did
not demonstrate any direct analgesic effect of the in-
tervention. Patients enrolled in these studies under-
went a variety of surgical procedures, including am-
bulatory and major inpatient surgery, and doses
ranged from 0.15 to 1 mglkg. There was no obvious
effect of surgical type on the success of the preventive
intervention, and success did not depend on the dose
administered.
Ketamine was administered IV in nine positive
studies and seven negative studies, epidurally or in-
trathecally in four positive and three negative studies,
and subcutaneously in one positive study. Most stud-
ies (both positive and negative) coadministered opi-
oids with ketamine. However, in two positive studies,
an analgesic benefit was demonstrated with the
NMDA antagonist alone (without coadministered opi-
oid) (1.76,121).
Twenty of 24 studies documented evaluation of ad-
verse effects, including psychomimetic effects. Twelve
studies documented no adverse effects. Seven studies
documented adverse effects but found no difference
between treatment and control groups. One study
documented psychomimetic effects related to epidural
ketamine 20 mg (1,20).
Twelve studies examined the use of dextromethor-
phan (Table 4), and eight (67%) demonstrated evi-
dence of a preemptive or preventive analgesic effect.
Three studies used a preemptive (136,138,145) and
nine studies used a preventive design. Of the four
negative studies, two (1.41.,142) did not demonstrate
any direct effect of the analgesic intervention.
Both positive and negative studies used a variety of
major and minor surgical procedures, and the success
of the preventive intervention did not appear to be
associated with the type of surgery. Dosages varied
from 0.5 mg/kg, to 15d mg ana-aid not aplear to be
associated with the success of the intervention. Two of
the studies in the negative group (1.41.,142) used a
smaller dose by the oral route that was not associated
with a direct analgesic effect. Positive studies used
both oral (four studies) and IV or IM routes, whereas
all four negative studies used the oral route.
All but one study coadministered an opioid for
analgesia, and therefore preventive analgesia may
have been related to a reduction in opioid tolerance in
many studies. One study (1af that did not use a
coadministered opioid demonstrated a direct analge-
sic effect of the dextromethorphan itself.
Table 3. Studies Examining Ketamine That Met Inclusion Criteria
Quality scoreStudy 
. 
(0-s)
Coadmin
No. Patients/procedure opioid
Groups
(treabnent combination)
Aida (112) 4 lz1./distal or total gasfrtrtony
Choe (113) 3 60/subtotal gastrectomy
Yes Premed hy&oxyzine 1 mg/kg + atropine 0.01 mglkg
GA plus:
G1: MORep-
G2: KET IV
G3: COMB
G4: control
Yes GAplus epiduraf
G1: Morph + KET pre-ind
G2: Morph + KET intra-op
Yes Mirlazolam 1-3 mg lV pre-med * ientmyl 50 ;rg IV
Infusion of study drug duing srugery:
G1: propofol alone
G2: propofol + KET 0.98 mglml
Yes GA + bolus study dmg follon'ed b)'48-h infusion
G1: KtrT: 0.5 mg/kg bolus + 2 mg . kg-l . rnin-l for 24 h then
1 mg , kg-r . tin-1 up to 48 h
G2: placebo: saline bolus * infusion only
Menigaux (123) 4  5/arttstxcopic ACL repair Yes Premed oral hldroxlzine 100 mg
1-2 h pre-op
GA plus:
G1: pre-inc;
trGT * saline
G2: Post-inc;
Saline"l- KET
Control group: saline + saline
Tverskoy (1.33) 3 l8/unilateral & bilateral hemionhaphy Yes GA plus: bilaieral repair-Bupiv + KET & Bupiv
Unilateral repair-Bupiv + KET or Bupiv
Fu (115) 3 4}/abdominalsurgery Yes Midazolam 0.05 mg/kg at induction
GA plus KET; Pre-inc bolus * infuion
Posi-inc bolus only
Yes Pre'med diazepam 5 mg IV
Group G: CA + post-inc intervmtion
Group EB: epidual + pre-inc intervention
Croup EA: epidual * post-inc intenention
Wong (34) 2 4s/total knee replacement
Hinrmelseher (116) 5 37 /un11ateral total hree arthroplastv No Midazolmr 3.75J.5 mg oral pre-med 1 h pre-op
G1: epidural Ropiv + S(+)-KET & sedation
C2: epidural ltopiv * saline & sedation
Menigaux (124) 5 50 / arthrmcopic mmiscal surgery Yes Hyc'lroxyzine 100 mg oral pre-med, 1-2 h pre-op
GA TCI propoibl plus;
G1: KET
C2: control
IVlortero (125)
Stubhaug (129)
3 39/day surgery
5 2Olnephrectomy
Table 3. (Conthued)
Route/dose/timing Systemic-anqlgesic
Direct
analgesic effmt Preventive/preemptive analysis'
IV KET bolus 1 mg/kg 10 min pre-inc + infusion Naloxone 0.008 mg/kg IV at end of surgery Yes Prevenfir'e effec! lowest VAS & Analg. Req.
at 0.5 mg 'kg-t ' 6-t until skin closue Post-op PCA morphine over 48 h with combination of MORep &
Epidural morphine bolus 0.05 mglkg 40 min pre- W KE.J
inc * infusion at 0.02 mg'kg-r ' 1-r mtil skin COMB < KET IV < MORep < control
clmure- Significant difference in VAS & Anaig. Req.
MORep: MORep only over 48 h
KET IV: KET IV only
COMB: both MORep & KET IV
Control sline epidural and IV bolts + infusion
Epidural iniction Post-op epidual Ys Preemptive effec! more supplemenial
G1: KET 60 mg * morphine 2 mg preind of GA Bupir' 0.25ol. 8 mL + 2 mg morphfure analgesia required in G2 r'ersus G1;
& 8 rnl of sline intra-op after removal of duation of analgesia G1 > G2
specinen
C2: 8 mL of sline pre-ind of GA & KET 60 mg +
morphinc 2 mg intra-op after removal of
sPecmen
IV bolus injections; 10 min after induction, before Su{entanil 0.2 g/kg + 0.25 mg ' kg-l ' min-r Yes Preventive effec! significmt difference in
inflation of tomiquet, and at end of surgery post-op PCA morphine Analg. Req. over 24 & 48 h
Preinc: KET 0.15 mg/kg at induction & saline at Control > Preinc = Post-inc; no significant
endofsurgery differenceinVAS
Post-inc: saline at induction & KET 0.15 mg/kg at
end of surgery
Control saline both at induction and end of
surgery
10 mL wound infiltration at end of surgery Post-op dipyrone 0.5 g PO meperidine 25 mg Yes Peri.pheral preventive effecf in patients with
Bilateral<ne side Bupiv 0.5'1, + KET 0.3ol. & IM bilateral repair pain threshold level
oiher side increased with addition of KET to Bupiv
Bupiv alone compaecl n'ith contralateral side
Unilateral<aps randonized to receive either
Bupiv 0.5% + KET 0.3% or Bupir' 0.5?o alone
IV KET bolus 0.5 mglkg * infmion No intra-op opioids; postop PCA morphine Yes Preemptive effec! significant difference in
10 mg. kg-i 'min-r Analg. Req. over 48 h;
Pre-inc: bolus at induction * infusion started & Post-inc ) Pre-inc; no signficmt difference
discontinued at womd closue in VAS
Post-inc: bolus at wound closure only
Group G: GA plus pre-inc epidural saline 15 m! Post-op PCA morphine & 10 mL epidural Yes Premptive effect
inka-op epidural saline 10 mL * morphine bolus of lidocaine 0-329i, * morphine 1 mg Group EB: epidural * pre-inc
1.5 mg * KET 20 mg 30 min after skin incision + KET 10 mg every 12 h for 72 h interuention-least Analg. Req. and
Group EB: epidural lidocaine 2o/o L5 mL & lowest VAS at 12 & 72h
morpirine 1.5 mg + KET 20 mg 30 nin pre-inc Group EB ( Group EA < Group G
Group EA: pre.inc epidural liclmaine 2% 15 mL &
morphine 1.5 mg + KET 20 mg 30 min post-inc
htra-op sedation with IV propofoi or midazolam l'jost-op PCEA Ropiv rescue malgesia; Yes Preventir.e effecl Ana$. lteq. (PCEA i{opiv)
in all cass diclofenac 50-100 mg or acetaminophen & VAS at 24 & 48 h G2 > G1
Bolus Ropiv 45 nin preop 0.5-1 g I']R iollo*'ed by metamizoi 1-2 g Time to first analgesia, slrury block similar
Inten'ention 10 min pr*inc IV penistent pain; Ropiv epidrual bolus or Aralg. Req. NSAIDs & opioids
Epidrual block dermatome >T12 in{usion G1 = G2
G1: Ropiv 1% 10-20 mL epidwal bolus + S(+)- Ilritramide 1.5-7.5 mg SC/IV or JV PCA
KLT 0.25 mglkg
G2: Ropiv 1% 10-20 mL epidural bolus l- saline
GA TCI propofol intervention; fV bolus just a{ter Alfentanil 20 pg/kglA Bupir. 0.5% * Ym Preventive effec! Ana1g. Req. & VAS
induction norphine 5 mg at end of arthroscopy throughout studv
G1: KET 0.15 mglkg KET diluted in 10 mL of Post-op morphine 3 mg every 5 min PRN KET ( controi
saline All patients received naproxen 550 mg on
G2: conkol 10 mI" saline discharge; naproxm 550 mg +
acetaminophen 800 mg/
dextropropox,rrphene 60 mg everu 6 h PRN
lnfusion of study drug pre-op In PACU: morphine 2 rng IV for VAS ) Yes Prerrentive effec! pain and malgesic
0.3"0.5 mL ' kg-r ' 
-;t -l 30 mrn consmption significmtly reduced on
Fentmyl 50 pg increments for pain Hydrocodone I'O for pain after discharge Day 3 post-op
Post-ind of GA and pre-inc inten'ention PCA morphine for post-op pain Yes Preventive effec! significantly reduced area
KET 0.5 mglkg IV bolut then of punctate hllperalgesia in the KET
2 mg.kg-1 'nrin-r infusion for 24 [ then group up to seventh postoperative day
1 mg'kg-r 'min-l infusion for 48 h and reduced nind-up pain on Day 3
Placebo IV bolus and infusion of idmticai voltmes
of saline
Table 3. (Continued)
Study
Quality score
(0-s) No. Patients/procedure
Co.admin
opioid
Groups
(treatrnent combination)
I-auretti (121) 60lanterior and posterior vaginoplasty No IV midzolm pre-.med 0.05 mglkg + study drug
Tverskoy (132)
Tanaka (131)
Subramaniam (130)
Mathi*n (122)
Papaziogas (126)
laksch (118)
Dahl (1 14)
Kafiirvel (i19)
Hrung (117)
Ro)'tblat (128)
Kirdemir (120)
27 /TAI)
66lminor pediatric surgery
40lmaior upper abdominal surgery
60 /laparoscopic cholecystectomy
S3/laparoscopic choiecystectomy
3O/arthroscopic ACL repair
89/TAH
30/intracar'itv bradrytherapy for
carcinoma of cen'ix
60/knee arthroscopy
22 / op at cholecystectomy
3O/abdominal surgery
IVfidazolam 2 mg W pre-med GA with;
G1: fmtanvl
G2: KET
G3: control
I'R premed shrdy drug pre{A;
G1: midazolam
G2: KET:5 mg/kg
G3: KET:7 mg/kg
G4: KET: 10 mglkg
Pre-med diazepam 10 mg 2 h pre-ind
10 nL epidurai study drug
G1: MORep
G2: KET + MORep
Pre'ind midazolam 2 mg IV
GA plns;
PRE: (R)-KET
I{ST: (lt)-KET placebo; saline
Oral diazepam 0.15 mglkg t h pre-op GA plus;
G1: pre-inc placebo
G2: pre-inc placebo * Ropiv 0.101" infi.r-sion
G3: pre-inc KET + Ropiv 0.1% infusion
Oral midzolam 7.5 mg pre-med t h pre-inc GA p1m;
KET or saline
Midaz-olam 0.07 mg/kg IM t h preop GA plus;
C1.: placebo
G2: pre-inc KET
G3: KET at skin closure
Dazepam 0.2 mg/kg PO 2 h pre-op
Spinai anesthesia u'ith;
Bupiv alone
Bupiv + KET
Spinal mesthesia *
G1: IA saline
G2: IM KXT 0.5 mglkg
G3: IA KET 0.5 mg/kg
CA+
G1: KET 0.15 mg/kg W
G2: saline
GA * thoracic epldural with 12.5 mg Bupiv *
G1:50 mg KET
G2: 0.5 mg neostigmine
G3: saline control
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
No
Yes
Table 3. (Continued)
Route/dose,/timing Systenic malgesic
Direct
analgesic effect Preventive/preemptive analysis"
LJ1OUPS:
1. IV saline + IT Bupiv 20 mg
2. IV saline + IT Bupiv 20 mg + tt neostigmine 50 pg
3. W KET 0.2 mglkg + IT Bupir' * saline
4. IV KET O.2mg/kg + IT Bupiv 20 mg + IT neostigrnine 50 pg
5. IV fmtan;zi 1 pg/kg + IT Bupiv * saline
5. W fentanyl 1 pg/kg + IT Bupir'20 mg + ITneostigmine50 pg
GA: Thiopental 3 mglkg induction of msthesia & isoflurane
maintenarce
hrtenmtion: IV injection as part of GA md intra-op mafurtorane
infusion
Fentanyl: GA + fenimyl 5 pg/kg + 0.02 mg .kg-r . 
-;tr-r
KET: GA + KET 2 mglkg + 20 mg.kg-t ' 
-ir.-t
Control GA only
Observed after premed before GA
GA induced * maintained Sevo + 67% N2O
Intubated after atropine 0.01 mg/kg * vemonium 0.1 mg/kg
Midazolam: 1 mglkg 1.5 min before GA
KET: 5 mglkg 45 min before GA
KET: 7 mg/kg 45 min before GA
I(ET: 10 mg/kg 45 min before GA
Epidural catheter inserted pre-inc iniection
Gl: MORep 50 pg/kg
G2: epidural morphine 50 pglkg + KET 1 mglkg
IV injection at 3-10 min preinc & at skin closure
PRE: (R)-KET 1.0 mglkg pre-inc & saline at skin closue
POST: saline pre.inc & (R)-KET 1.0 mglkg at skin closure
Placebo: saline pre-inc & saline at skin closure
Pre-inc IV bolus intervention
Pre-inc locai inflltration o{ port sites u'ith 20 mL Ropiv 1%
G1: IV saline * saline infilhation
G2: IV saline * Ropir'1% infiltration
G3: IV KET 1. mg/kg * Ropir, 196 infilkation
After induction & at least 5 min pre-inc IV bolu followed by
50 mL infusion uatil 2 h after emergence from mmthesia
KET: 0.5 mg/kg boius + 2 mg'kg-t . h-r **'orl
Saline: 0.1 ml/kg bolre + 0.06 rng ' kg-l . h-r infusion
IV bolus 5 min befcrre skin incision and on completion of skin
closure
G1: saline pre-inc & saline at closue
G2: KET 0.4 mg/kg pre-inc & saline at closure
G3: saline pre-inc & KET 0.4 mg/kg at closure
Spinal anesthesia with hyperbaric Bupiv (0.5%) 10 mg or
hyperbaric Bupiv (0.5%) 7.5 mg + KET 25 mg
Spinal anesthesia u"ith 12.1-15 mg Bupiv
IA or IM injection given on completion of surgery
GA induding 3 trglkg fentmyl
tr(ET or saline given 5 min before sugical incision
GA with no supplemental malgesics
Diclofenac 75 mg IM if
necessary for post-op pain
Post-op
G-9 h PCA meperidine
9-24 h meperidine 50 mg every
4h
Acetaminophen 50-1ffi mg PR
pentazocine 0.5 mg/kg IV
NtO intra-op
IV morphine 0.05-0.2 mglkg
intraop MORep 0.05 mglkg
post-op
Preind IV ketorolac 30 mg
Irrduction {entmyl 1.5-2.0 pg/
kg bolus
Bupiv skin infiltration pre-inc
lntra-op alfentmil 0.$-1.0 mg
bolu if required
Post-op PCA meperidine *
acetarrinophen 1G PR
Acetaminophen 5m mg +
codeire 30 mg at home
Fentar,vl 3_5 pglkg post-op
Dclofenac 50-100 mg PR
dextropropoxyphene 75 mg
PC) meperidine 50 mg Ilvl
Remifentmil 0.125-
r.rJ mg.Kg .Im lJ mm
before wornd closure
lomoxicam 8 mg &
m^.^hin- ( 
--
Post-op morphine PCA
Alfentanil 15 pg/kg
ketobemidone 4 mg W
Post'op ketobemidone 1 mg IV
Acetarninophen 1G every 8 h PR
No intra-op opioids/NrO post-
op dlcloferuc 75 mg M
Rescrre pain relief with
meperidine 1 mg/kg every
4 h if required
PCA morphine + continuous
infusion
Epidural morphine 2 mg on
VAS >3
Preventir.e effecf significantly decreased
VAS at 24 h in KET/neostigrnine group
- 
-- -Tompared with control
Prevsrtive effecti signficmt decreare in
h.lperalgesia at 48 h
KET=fentanyl<control
Preventive effect significant inaeased time
to fust analgesia in KET: 7 mglkg &
KET: 10 mglkg groups compared with
midazolam & KET:5 mg/kg groups
Preventive effec! significmt increared time
to first analgesia; G2 > G1
Analg. Req.; G2 < Gl
No preventive effecg no significant
difference in VAS or Analg. Req.
PCA mcperidfure or othor malgcsic
consumption at 4 19 24 h & 7 days
PRE = POST = placebo, direct aaalgesic
effeci occuned in post group
No preventive effec! no significant
difference in VAS at 24 & 48 h G1 : G2
=G3
Analg. Req. G1 > G2 = G3; direct analgesic
effect occuned in G3 at 6 and 12 h
No preventive effec! no significmt
differmce in VAS or Analg. Req.
No preventive e$ect; no significant
difference in VAS or Analg. Req.
G1 : G2 = G3; direct effect of KET in post
group at I h
No preventire effect; no sigrtficmt
dif{erence in VAS or Analg. Iteq.
Bupir' * KET more side effects
No preventive effect
No preventive effecf direct malgesic effect
with reduced VAS up to 4 h ald reduced
cumulative morphine coromption over
z+n
No preventive effmt
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
No
No
No
No
Table 3. (Continued)
Study
Quality score
(0-s) No- Patients/prredure
Co-admin
opioid
Groups
(treahnent conrbination)
Peat (127)
Wilder-SmitJr (135)
20/TAH
45ITAH
Epidural after induction oI GA
G1: KET
@: diamorphine
Before & after induction;
GL: fentanyl
G2: magrsim
G3: I(ET
Co-admin = coadministered; Pre-med = premedication; GA : general anesthesia; MORep = epidural morphine; KET = ketamine; tsupiv = bupivacaine;
Ropir.=ropivacaine;Sevo=sevoflurane;Sf=subcutaneotts;PO=perora!PR=perrectumiCOMB=combination;PCA=patient-conkolledanaigesia;
VAS = r'isual analog scale; Analg. Req. = anaigesic requirement; PACU = postanesthesia care unit Pre-ind = pre-induction; Pre-op : preoperative; Pre-inc =
Preincision; Post-inc : postincision; Intra-op = during surgery; Post-op = after strgery; PCEA = patient-controlled epidwal analgesia; TCI : target-controlled
infusion;IT=intrathecal;lA=intraarticularjACL=anteriorcruciateligame'n!TAH=totalabdominalhysterectomy;G=group;Pre-GA=beforegeneral
anesthesia; PIIE = be{ore; POST = after; TCI = target-controlled ilfusion; PRN = as needed; NSAID = nonsteroidal antiinflarnmatory drug.
" Preventive analysis colum concems pain and,/or analgesic consumption only beyond five half-lives of N-meth14-n-aspartate mtagonist administration.
Adverse effects related to opioids were described in
11 of 12 studies. but no statistical difference was de-
termined between groups. One study did not docu-
ment adverse effects (147).
Four studies examined magnesium, and none
demonstrated a preventive analgesic benefit (Table
5). Two of the four studies did not demonstrate a
direct analgesic effect. Surgical type was limited
to major abdominal or pelvic surgery, and all stud-
ies coadministered an opioid. Magnesium was ad-
ministered by the IV route in all four studies. All
studies documented opioid-related adverse effects
but no statistical difference was found between
groups.
Discussion
Adherence to the narrow definition of preemptive
analgesia that currently dominates the literature
may have led to a large proportion of negative
results. This is especially true for studies that did
not include a placebo control group to control for
the possibility that the presurgical and postsurgical
interventions provided an equal overall benefit in
reducing central sensitization (7,154). This method-
ological shortcoming has limited the potential clin-
ical utility of the narrow definition because central
sensitization may be induced by noxious stimuli
throughout tl-re perioperative period and not only
by skin incision (7,154). The limited clinical utility of
the narrow definition of preemptive analgesia was
demonstrated by a recent systematic review (6).
Preventive analgesia provides a broader, more clin-
ically relevant concept in which the administration of
a drug at any point in the perioperative period and the
presumed associated reduction in centrai sensitization
may reduce pain, analgesic consumption, or both
beyond the clinical activity of the target drug. The
NMDA antagonists would appear to be potentially
useful drugs in this regard because of their effect in
reducing central hypersensitivity and wind-up-like
states in humans.
The results of this systematic review showed that
ketamine and dextromethorphan produced a signifi-
cant preventive analgesic benefit in 58% and 670/o of
studies, respectively. This is in addition to the benefit
that in all positive preventive studies, a direct analge-
sic benefit of the drug occurred in the early postoper-
ative period. It is interesting that in a large proportion
(56%) of the studies that did not find a preventive
analgesic effect, a direct effect of the target drug also
was absent. This strongly suggests that central sensi-
tization was unaffected by these interventions, both
immediately and in the longer term.
NMDA antagonists may reduce pain, opioid con-
sumption, or both by two non-mutually exclusive
mechanisms. The first is the more widely recognized
reduction in central hypersensitivity, but NMDA an-
tagonists have also been seen to reduce opioid toler-
ance in many animal and human studies. In this re-
view,22 ketamine and 11 dextromethorphan studies
coadministered opioid analgesics with the NMDA an-
tagonists. The analgesic benefit or reduction in opioid
consumption in these studies therefore may have been
due, at least in part, to a reduction of acute opioid
tolerance. The other three positive studies (two ket-
amine and one dextromethorphan) did not coad-
minister opioid with the NMDA antagonist, sug-
gesting that the reduction in pain intensity or
analgesic use was due to an NMDA-mediated re-
duction in central sensitization brought about by the
preventive analgesic intervention (although other
possibilities include effects due to drug action at
other receptor sites).
Many surgical procedures were included in both
positive and negative studies, and there did not ap-
pear to be one specific procedure that yielded more
benefit than any other. In the dextromethorphan stud-
ies, all four negative studies used the oral route, and in
two of these trials at smaller doses of drug, there was
no direct analgesic effect of the intervention.
Table 3. (Continued)
Route/dose/timing Systemic analgesic
Direct
arulgesic effmt Prevantive/premptive analysl{
Epidural injection during closure of wound
G1: KET;30 mg in 3 mL saline
G2: diamorphine;5 mg in 3 mL saline
3 mir preind IV bolus interuention
5 min pre-inc W bolus intenmtion
C1: fentanyl 1.5 pg/kg + 0.75 pg/kg
G2: nragnesium 20 mg/kg + 10 mglkg
G3: KET 0.5 rry/kg + 0.25 mg/kg
Intra-op fentanyl 3 pg/kg
Morphlre PCA
No preventive effect
No preventive effect, no significant difference
in VAS or Analg. Req. between groups
It may be that dextromethorphan should be admin-
istered parenterally in a dose of at least 1 mg/kg for
maximal preventive effect. A variety of doses of ket-
amine, from 0.15 to l rng/kg, were used, although the
spread of doses was similar in both positive and neg-
ative studies.
Magnesium demonstrated no preventive analge-
sic effect in the four studies examined. It is difficult
to understand why magnesium should have less
effect than other drugs. It is possible either that the
magnesium is removed from extracellular fluid rap-
idly or that the ion is specific to the NMDA receptor
channel and does not influence the receptor sites to
which other NMDA antagonists bind and thus re-
duce pain, analgesic consumption, or both. It is
important to note that in two of four studies, the
administration of magnesium did not demonstrate
any direct benefit (pain or analgesic reduction) and
that, therefore, it is unlikely to have shown effects
later in time.
This is the first systematic review to attempt to
evaluate the efficacy of preventive analgesia by exam-
ining the analgesic benefit five half-lives beyond an-
algesic administration. It was critical to select this time
point because unlike with most studies of preemptive
analgesia, preventive analgesia does not involve a
postincisional analgesic intervention. We chose five
half-lives to exclude as much as possible any direct
effect of the NMDA antagonist. However, to avoid
excluding most studies, we chose a point at which
<5"/o of the plasma drug concentration would remain.
We could be criticized for being overly stringent and
might have chosen, for example, three half-lives. In
fact, changing the criterion to three halflives would
lead to inclusion of an additional six studies: two of
these were negative (one dextromethorphan and one
magnesium), and four, all using ketamine, were pos-
itive. Therefore, changing the cutoff to three half-lives
would actually strengthen our review for the ket-
amine result, slightly weaken the dextromethorphan
result, and leave the magnesium result unchanged.
This systematic review was limited to English-
language reports and therefore may be missing data
from important studies published in other languages.
Flowever, it has been reported that language-limited
reports do not lead to biased estimates of intervention
effectiveness (155). If the same holds true for the field
of preventive analgesia, then our exclusion of the non-
English literature would be not be expected to alter
our findings and conclusions.
A number of areas remain {or future investigation
with the NMDA antagonists. NMDA receptors have
been isolated in the peripheral nervous system, and
NMDA antagonists have been demonstrated to pro-
duce analgesic benefit in animals and volunteers (156-
158). Further research is required to determine benefit
in the clinical setting.
Many studies coadminister NMDA antagonists
with opioid analgesics and may produce benefits
through a reduction in opioid tolerance (159). Further
research is required to determine whether NMDA
antagonist-mediated analgesia is effected through re-
duction in opioid tolerance or whether these drugs
have analgesic benefit in isolation. Future studies
should also focus on design issues, such as appropri-
ate control groups, standardization of pain assess-
ment, and analgesic consumption data coilection (10),
to allow for quantitati','e systematic review and
meta-analysis.
In most studies included in this systematic review,
the perioperative administration of ketamine and dex-
tromethorphan reduced pain, analgesic consumption,
or both immediately and beyond the clinical duration
of action of the drugs used preventively. The most
likely mechanism is a reduction in NMDA receptor-
mediated central sensitization.
Table 4. Studies Examining Dextromethorphan That Met Inclusion Criteria
Study
Quality score
(0-s) No. Patients/procedue
Co-adnrin
opioid
Croups
{treatrnent conrbination)
Helmy (138)
Chia (i36)
Wu (145)
Kawamata (1i14
Weinbroun (li3)
Weinbroum (1t14)
Henderson (139)
wu (14s)
IvfcConaghy (141)
Ilkiaer (153)
Grace (137)
Rose (1412)
60lupper abdominal surgery
60/iorer abdominal sugery
60/upper abdominal surgery
36ltonsillectomy
50 / day swgery, inguinal hemiorrhaphy,
lon'er limb afiluoscopy
75 / day *rgery, inguinal hemiorhaphy,
lower limb arthroropy
47 /TArl
90llaparoscopic cholerystectomy
53/TA,H
Yes GA plus;
PRE: Dex/saline
POST: saline/Dex
Control: saline/saline
GA plus;
PRE: Dex/saline
POST: saline/Dex
GA plus;
Control
Dex 10 rng
Dex 20 mg
Dex 40 mg
GA plus;
Control
Dex 30 ng
Dex 45 mg
Single-shot epidural lidocaine plus;
Control
Dex 60 mg
Dex 90 mg
lA; sirrgle-shot epidural lidocaine L.6% 1,6 mL
LA + control
GA * control
LA * Dex90mg
GA + Dex 90 mg
GA pft.s:
G1: Dex
G2: placebo control
GA plus;
Conkol-{PM 20 mg pre-op
Group A-Dex 40 mg intra-op
Group B-Dex 40 mg pre-incision
GA plus;
G1: Dex
G2: placebo
GA plus;
G1: Dex
G2: placebo
No
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
5OlTAH
4 37/\aparotmy
5 s7ladenotonsillectomy (pediatric)
Yes GA phrs;
Pre-rned
G1: Dex
G2: placebo
Yes GA plus:
G1: Dex 0.5 mg/kg
G2: Dex 1.0 mg/kg
G3: placebo
Co-admin = coadministered; Dex = dextromethorphan; PO = per oral; PCA : patient-controlled analgesia; Post-op = postoperative; Pre-op = preoperative;
Pre-med = premedication; Analg. Req. : anaigeslc requirement; VAS = visual analog scale; PRI.J : on demand; LA = local anesthetic; CPM : chlorpheniramine;
CI{EOPS = Children's Hospital of Eastem Ontario Pain Scale; TAH = total abdominal hysterectoml'; GA = general anesthesia; G = group; intra-op = dasint
surgery; pre = before; post = after; PACU = postanesthesia care unit; PR = pel recium.
" Preventive analysis column concerns pain and/or analgesic consumption only beyond fir.e halflives of N-methyl-l-aspartaie antagonist administration.
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Table 4. (Continued)
Route/dose/timing Systemic malgesic
DLect
aralgsic benefii Pre'l.mtive/preemptive malysi$'
IM injection intervention; 30 nrin pre-incision
and then 30 min before end of surgery
PRE: Dex 120 mg IM then saline IM
POST: saline IM then Dex 120 mg IM
Placebo: saline IM then mline IM
IV in{rsion
Dex: 5 mglkg in 300 mL saline/3O min
Saline:300 mL saline/30 min
PRE: 30 min preinduction
POST: during skin clmue
ItuI injection 30 min pre-incision
Control com 20 mg
DEX-10: Dex 10 mg
DEX-20: Dex 20 mg
DEX-40: l)ex 40 mg
Oral pre'med 60 min pre-induction
Control: starch tablet
DEX-30: Dex 30 mg
DEX-45: Dex 45 mg
Oral capsule
90 nin pre-induction
Control: placebo
DEX-60: Dex 60 mg
DEX-90: Dex 90 mg
OraI tablet 90 min before surgery
LA * placebo
GA + placebo
LA + Dex90 mg
CA + Dex 90 mg
GA+
G1: Dex 40 mg pre-med * 4 h post-sugery
and then every 8 h for next 48 h
G2: placebo control tablets as G1
Control-{PM 20 mg IM 30 min pre-op
Group A: Dex 40 mg IM after removal of
gallbladder
Group B-Dex 40 mg IM 30 min preop
Oral capsule
Night before surgery and 1-2 h preop md 8,
16, 24 h post-op
Cl:Dex27 mg
G2: placebo
Oraltabletlhpre-op
G1: Dex 150 mg
G2: placebo iablet
Oral capsule
Night before surgery and t h pre-op
C1: Dex 60 mg
G2: placebo
Oral preparation 60 min pre-op
G1: Dex 0.5 mg/kg
G2: Dex 1.0 mg/kg
G3: placebo
Fentanyl 2 pg/kg
Post-op meperidine PCA
Fentanyl 3 pglkg
Post-op PCA
Morphine
Fentanyl 2 pg/kg
Post-op PCA
IVforphine
No intraop oploids
Post-op loxoprofen 60 mg every 8 h PO +
diclofenac 50 mg PRN suppositorv
Post-op analgesia
Morphine PCA first 2 h in PACU
Dclofenac 75 mg M PRN next 4 h in PACU
Diclofenac 50 mg PO PRN after discharge
Intra-op fmtanyl 2.5 pg/kg
Post-op analgesia
Morphine PCA
Diclofenac 75 mg IM PRN
Dclofenac 50 mg PO PRN after discharge
Intra-op fmtanyl 1.5 14/kg,
PCA morphine for postoperative pain
Fentmyl 2 pg/kgtnva-op
Meperidine 1 mg/kg M post-op
Morphine 0.1-{.15 mglkg
PosFop PCA morphine
Fentmyl 300 pg + 50 pgl30 min boiuses
Post-op PCA morphine
PCA morphine
IV morphine 0.075 mglkg
PR aceianrinophen 25-35 mg/kg
Preemptive effec! median pain scores similar
except at 6 h
Z hPCA constmption signficantly reduced in
PRE group
Preemptive effc| morphine requireme'nts higher
in IIOST group thm PRE group m Day 1 ald 2
Preventive effecf all data showed dosedependert
better pain relief in Dex-prenedicated patients
Prevmtive efl-ec! significantly lou'er VAS and
Analg. Req. in Dex compaed with conkol
DEX-30 = DEX-45
Prevmtive effec! significantly lower Analg. Roq.
and VAS in DEX-60 and -90 compared with
control
Preventive ef{ecf 50% lower Analg. Req. and VAS
in flEX-90 versus control a GA or LA
Prevantive effec! deceased VAS on movement
and analgesic consmption at 72 h
Preempfive effmt; time to 6rst malgesia
significmt Group B > Group A ) control
No prevmtive effecl no significant difference in
hlperalgesia/Aralg. Req./VAS at 48 h or 1 mo
No preventir.e effecf no significmt difference in
hyperalgesia/Analg. Req./side e'ffsts at 24 h
or3mo
Reduction in morphine consumption in Dex
group in first 4 h = direct analgesic effect
No preventive effec! reduction in early morphine
conflmption in Dex group = direct analgesic
effect
No significmt difference post-op Analg. Req. at
24h
No preventive effecl no significmt difference in
Analg. Req./CFItOPS/VAS/side effects at 24 h
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
No
No
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Table 5. Studies That Examined Magnesium and Met Inclusion Criteria
Study
Quality score
(0-5) No. Patients/procedure
Co-admin
opioid
Groups
(treatment combination)
Zanuza (150)
Tramer (149)
Ko (148)
Wilder-Smith (151)
92 / electl e colorectal surgery
42lelective TAH
58/elective TA}I u'ith lower
midlilre incision
24lelective TAH
GA plus;
G1: control
G2: MgSOa
GA plus;
G1: control
G2: MgSOn
Fentanyl 1 Srg/kglM
1 h pre-op
G1: placebo
G2: MgSOn
Yes GA plus;
Group C: control
Group NFnifedipine
Group NM: nimodipine
Group MG: MgSOn
Co-admin = coadministered; GA : general anesthesia; VAS = visual analog scale; Analg. Req. : analgesic requiremenf PCEA : patieni-controlled epidr.rral
analgesia; Post-op : postoperative; I\rI = IV infusion; TAH : iotal abdominal hysterectomyi MgSOu : magnesium sulphate; pre-op : before surgery; pre =
before; post : after; pre-med : premedication; intra-op = intraoperative.
" Preventive analysis colum concems pain anel/or analgesic consumption only beyond five half-lives of N-methy'1-n-sspartaie antagonisi administration.
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Table 5. (Continued)
Route/dore/timing Systen{c q4qlgesic
Direct
analgesic bmefit Prevmtive malysis'
Oral tablet placebo or study drug
3 h before srugery
(20 min post-induction IV bolus * start 20 h IV infusion
of placebo or study drug
Group C: placebo tablet * W bolus + I\rI
Group NF: nifedipine 60 mg + placebo bolus * IW
Group NM: placebo tablet * bolus * nimodipine
30 mg . kg-l . h-l IVI over 20 h
Group MG; placebo tabiet + MgSO4 30 mglkg bolus +
10 mg. kg-I .h-1 WI or.er 20 h
Post-induction bohrs * W bfusion 20 h
C1: saline 15 mL bolus + 2.5 mllh WI
G2: MgSO, 209i' 15 mL bolus + 2.5 mllh IW
(13 g total dose)
W bolus * infusion for 6 h
G1: saline 0.2 mllkg bolus + IVI
G2: MgSOa 25% 50 mg/kg bolus
+ IVI at 15 mg . kg-l . h-l for 6 h
Slon'W bolus 5 min preinduction * contimrou fV
infusion{or5hpct-op
C1: placebo IV bolus + lV infusion
G2: magnsium 200 mg IV bolus + 200 mglh I\{I for 5 h
Fentanyl 4 Fglkg boh6 + infusion
r ng'Kg - 'n -
Post-op PCA morphine
If VAS >5;
2 g propacetamol W
2 g metamizole IV
Fentmyl
3 pg/kg, at induction
1..5 pg/kg at 5 min before incision
+ 1 pglkg bolm post-op PCA morphine
Post-op PCEA (bupivacaine 0.05% +
fentaayl 5 pglml-)
Fentanyl 1 pglkg IM premed
Alfmtiuril 15 pglkg W bolus at induction
+ intra-op IV infreion at
0.0H.05 mg.kg-r . mjn-l
Morphine I'CA basal in{usion 0.5 ng/h +
bolus 2.5 mg n'ith 10 min lockout
No preventive effecb no significant
di{ference
VAS/A:ralg. Req./side effects
No preventive effecf Analg. Req.
significmtly reduced in MgSO,
group duing first 6 h post-op but
not tht'reafter
No preventive effecf no significant
differmce in VAS/Analg. Req.
No preventive effect; no significmt
difference in VAS/Analg. Req.
exceptatlhpost-op
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